share_log

Benchmark Maintains Buy on Clene, Lowers Price Target to $84

Benzinga ·  Nov 22 09:56  · Ratings

Benchmark analyst Bruce Jackson maintains Clene (NASDAQ:CLNN) with a Buy and lowers the price target from $90 to $84.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment